Home › Funds › GLENVIEW CAPITAL MANAGEMENT, LLC › EYE
GLENVIEW CAPITAL MANAGEMENT, LLC position in EYE
NATIONAL VISION HLDGS INC · Health Care
GLENVIEW CAPITAL MANAGEMENT, LLC reported holding 3,101,083 shares of EYE (NATIONAL VISION HLDGS INC) in its Q2 2026 13F filing — a position valued at US$59.0M, representing 1.13% of its reported portfolio and ranking #24 among its reported holdings. GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed EYE holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GLENVIEW CAPITAL MANAGEMENT, LLC's EYE position evolved
GLENVIEW CAPITAL MANAGEMENT, LLC first disclosed a stake in EYE in Q2 2025 at 812,534 shares (US$18.7M). The position peaked in Q2 2026 at 3,101,083 shares, worth US$59.0M. Across 5 filings, GLENVIEW CAPITAL MANAGEMENT, LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,101,083 shares valued at US$59.0M — an increase of 1,535,166 shares quarter over quarter.. Notable position changes include a 70% increase in Q3 2025 (shares fell 12% over the following quarter), a 98% increase in Q2 2026 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 812.53K | $18.70M | New |
| Q3 2025 | 1.38M | $40.23M | Add |
| Q4 2025 | 1.43M | $36.91M | Add |
| Q1 2026 | 1.57M | $40.56M | Add |
| Q2 2026 | 3.10M | $58.95M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EYE and 13F data
EYE (NATIONAL VISION HLDGS INC) is a Health Care company. 30 other funds we track also report a position in EYE — the largest reported positions include Engine Capital Management, LP (US$66.9M), EMERALD ADVISERS, LLC (US$38.1M), Divisadero Street Capital Management, LP (US$36.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EYE
- Engine Capital Management, LP 3.52M sh · $66.93M · Q2 2026
- EMERALD ADVISERS, LLC 2.01M sh · $38.15M · Q2 2026
- Divisadero Street Capital Management, LP 1.90M sh · $36.11M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 1.30M sh · $24.68M · Q2 2026
More on GLENVIEW CAPITAL MANAGEMENT, LLC
FAQ
How long has GLENVIEW CAPITAL MANAGEMENT, LLC held EYE?
GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed EYE holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is GLENVIEW CAPITAL MANAGEMENT, LLC's current position in EYE?
As of Q2 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 3.10M shares of EYE (NATIONAL VISION HLDGS INC), valued at $58.95M, representing 1.13% of its reported portfolio and ranking #24.
Has GLENVIEW CAPITAL MANAGEMENT, LLC been buying or selling EYE?
In the latest 13F filing (Q2 2026), GLENVIEW CAPITAL MANAGEMENT, LLC increased its position in EYE. The position peaked in Q2 2026 at 3.10M shares.
Which other funds hold EYE?
Other major institutional holders of EYE include Engine Capital Management, LP, EMERALD ADVISERS, LLC, Divisadero Street Capital Management, LP, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.